Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1CNS 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Spinal Cord Neoplasms 1Salivary Gland Neoplasms 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Optic Nerve Glioma 1Medulloblastoma 1Leukemia, Promyelocytic, Acute 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia, Biphenotypic, Acute 1Familial ependymoma 1Dendritic Cell Sarcoma, Interdigitating 1Congenital Abnormalities 1Choroid Plexus Neoplasms 1Carcinoma, Renal Cell 1Burkitt Lymphoma 1Blast Crisis 1Astrocytoma 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Cyclophosphamide 56fludarabine phosphate 30Filgrastim 28Peripheral Blood Stem Cell Transplantation 27Radiotherapy 26Cyclosporine 23Busulfan 23Etoposide 21Mycophenolic Acid 20Whole-Body Irradiation 19Antilymphocyte Serum 19Methotrexate 17Methylprednisolone 15Melphalan 14Cytarabine 13Vincristine 11Tacrolimus 11Thiotepa 10Prednisone 10Cord Blood Stem Cell Transplantation 10Rituximab 9Doxorubicin 9Leucovorin 7aldesleukin 6Granulocyte Colony-Stimulating Factor 6sargramostim 5Psychiatric Rehabilitation 5Carboplatin 5Therapeutics 4Daunorubicin 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Dendritic Cell Sarcoma, Interdigitating × CK0238273 × Clear all
NCT00363272 2013-01-16

Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma

National Cancer Institute (NCI)

Phase 1 Completed
30 enrolled
CNSLymphoidSarcoma

Familial ependymoma, Astrocytoma, Burkitt Lymphoma, Medulloblastoma, Spinal Cord Neoplasms, Choroid Plexus Neoplasms, Optic Nerve Glioma, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡